Contract Drug Discovery
The contract drug discovery process supports the complete pharmaceutical industry, surrounding the early stages of research from discovery of target and validation, right through to the detection of a drug candidate or lead compound. Preliminary detection of small therapeutic candidates comes about through a diversity of streams.
The contract drug discovery and contract drug development collectively are the whole process of discovering a novel drug and bringing it to market. Contract Drug Discovery may include screening of chemical libraries, detection of the active ingredient from a natural design or remedy resulting from an understanding of the target. Contract drug development entails studies on animals and microorganisms, clinical trials, and ultimately regulatory approval.
However, introducing a new drug to market is complex and time-consuming process that can cost pharmaceutical companies a huge lump sum amount. There are several defined stages for this process, each with their own associated timelines, challenges, and costs. The process of drug discovery includes - target discovery, lead compound identification, lead optimization, whereas the preclinical drug development includes broad testing in animal models to decide if the drug is safe for human trials and it if, it performs as it should.
Below is a list of suppliers who specialise in providing services related to Contract Drug Discovery:
Contract Drug Discovery Products
Search by Country
Ireland
Canada
India
Germany
United Kingdom
China
Switzerland
Ukraine
Israel
Japan
Australia
Spain
Belgium
Italy
Search by Supplier
Mallinckrodt Pharmaceuticals (5)
NanoString. (4)
Solid State Pharma Inc. (5)
Piramal Enterprises Ltd (5)
Coating Place, Inc (5)
Midas Pharma GmbH (2)
Owen Mumford Ltd (11)
STA Pharmaceutical Co. Ltd (4)
Adhesives Research, Inc. (5)
Eurofins Scientific (10)
Ypsomed AG (4)
Immatics (6)
Abzena ltd (9)
Biopharmasolutions baxter (2)
Aurigene Pharmaceutical Services Ltd (7)
Oasis Diagnostics® (5)
Cardinal Health (4)
FARMAK (5)
E3D Elcam Drug Delivery Devices. (5)
ALPEX PHARMA SA (5)
Lubrizol Life Science (1)
Onyx Scientific Limited (8)
Catalent, Inc (3)
Actiza Pharmaceutical (5)
Biocon (2)
Amneal Pharmaceuticals LLC (4)
Asahi Kasei Pharma Corporation (2)
Symbiosis Pharmaceutical Services (5)
Odan Laboratories Ltd (5)
ContraFect (5)
Mayne Pharma International Pty Ltd (3)
Merck Millipore (5)
Novo Nordisk (5)
ONO PHARMA USA (5)
ONCOMATRYX BIOPHARMA SL (4)
OncoDNA (3)
Olon S.p.A. (2)
F. Hoffmann-La Roche Ltd (4)